Know Labs Announces Successful Results from Pre-Clinical Study Validating Bio-RFID™ Platform Technology

SEATTLE, Wash. — June 9, 2021 — Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced successful results…

Know Labs Inc in Insights

Mar 24, 2021

Know Labs Confirms Particle Bulb Kills SARS-CoV-2

Know Labs Inc in Insights

Mar 15, 2021

Know Labs Announces Close of Financing

$14.2 Million for Product Development, Clinical Testing and Preparation for Up List to a…

Know Labs Inc in Insights

Dec 3, 2020

Know Labs Provides Update on Company Business, Impact of Covid-19

Know Labs Inc in Insights

Jul 21, 2020

Know Labs Enters into Research Agreement with Mayo Clinic

Know Labs Inc in Insights

Apr 13, 2020

Know Labs Announces Webcast with BioPub

Seattle, WA — April 13, 2020 — OTCQB: KNWN

Know Labs Inc in Insights

Apr 7, 2020

Know Labs Granted Patent for its Bio-RFID™ Technology

1 response

Know Labs Inc in Insights

Feb 5, 2020

Know Labs Releases Video Update

CEO Discusses IP, Improvements to Algorithm, and Website Redesign

Seattle, WA. — February 5, 2020 — OTCQB: KNWN

Know Labs, Inc. today released a video updating viewers on their latest progress. The link to the video can be…

Know Labs Inc in Insights

Jan 29, 2020

Know Labs Formally Announces its YouTube Channel

Know Labs Inc in Insights

Nov 21, 2019

Know Labs Unveils New UBAND Design and Smartphone App

Seattle, WA. — November 21, 2019 — OTCQB: KNWN

Know Labs, Inc. unveiled today a first look at its wearable UBAND™ Continuous Glucose Monitor (CGM) along with its companion iPhone App.

1 response

About

Insights

At Know Labs we’re making the non-invasive measurement of Blood Glucose a reality. Follow us on Medium to get exclusive updates and insights — first.

More information

Followers

Elsewhere